Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
Oana‐Patricia Zaharia, Klaus Straßburger, Alexander Strom, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 9, pp. 684-694
Closed Access | Times Cited: 469

Showing 1-25 of 469 citing articles:

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
Michael A. Nauck, Daniel R. Quast, Jakob Wefers, et al.
Molecular Metabolism (2020) Vol. 46, pp. 101102-101102
Open Access | Times Cited: 962
The integrative biology of type 2 diabetes
Michael Roden, Gerald I. Shulman
Nature (2019) Vol. 576, Iss. 7785, pp. 51-60
Open Access | Times Cited: 900
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Décio L. Eizirik, Lorenzo Pasquali, Miriam Cnop
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 7, pp. 349-362
Closed Access | Times Cited: 622
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 9, pp. 599-612
Closed Access | Times Cited: 580
Definition, Classification and Diagnosis of Diabetes Mellitus
Astrid Petersmann, Dirk Müller‐Wieland, Ulrich Müller, et al.
Experimental and Clinical Endocrinology & Diabetes (2019) Vol. 127, Iss. S 01, pp. S1-S7
Open Access | Times Cited: 511
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 398
Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics
Pauline Morigny, Jérémie Boucher, Peter Arner, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 5, pp. 276-295
Open Access | Times Cited: 353
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung, Karel Erion, José C. Florez, et al.
Diabetes Care (2020) Vol. 43, Iss. 7, pp. 1617-1635
Open Access | Times Cited: 297
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 296
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Juliana C.N. Chan, Lee‐Ling Lim, Nicholas J. Wareham, et al.
The Lancet (2020) Vol. 396, Iss. 10267, pp. 2019-2082
Closed Access | Times Cited: 291
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Róbert Wágner, Martin Heni, Ádám G. Tabák, et al.
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 49-57
Open Access | Times Cited: 282
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 239
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
Michael A. Nauck, Jakob Wefers, Juris J. Meier
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 8, pp. 525-544
Closed Access | Times Cited: 203
Mitochondrial alterations in fatty liver diseases
Bernard Fromenty, Michael Roden
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 415-429
Open Access | Times Cited: 193
Subtypes of Type 2 Diabetes Determined From Clinical Parameters
Emma Ahlqvist, Rashmi B. Prasad, Leif Groop
Diabetes (2020) Vol. 69, Iss. 10, pp. 2086-2093
Open Access | Times Cited: 166
Insulin resistance and insulin sensitizing agents
Lucia Mastrototaro, Michael Roden
Metabolism (2021) Vol. 125, pp. 154892-154892
Open Access | Times Cited: 162
Phenotyping Cardiogenic Shock
Elric Zweck, Katherine Thayer, Ole Kristian Lerche Helgestad, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 14
Open Access | Times Cited: 161
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung, Karel Erion, José C. Florez, et al.
Diabetologia (2020) Vol. 63, Iss. 9, pp. 1671-1693
Open Access | Times Cited: 156
Defining the underlying defect in insulin action in type 2 diabetes
Thiago M. Batista, Nida Haider, C. Ronald Kahn
Diabetologia (2021) Vol. 64, Iss. 5, pp. 994-1006
Open Access | Times Cited: 140
Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes
Dina Mansour Aly, Om Prakash Dwivedi, Rashmi B. Prasad, et al.
Nature Genetics (2021) Vol. 53, Iss. 11, pp. 1534-1542
Closed Access | Times Cited: 123
Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
Norbert Stefan, Matthias B. Schulze
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 6, pp. 426-440
Closed Access | Times Cited: 100
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
Christian Herder, Michael Roden
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1770-1781
Open Access | Times Cited: 93
Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes
Anand Thakarakkattil Narayanan Nair, Agata Wesolowska‐Andersen, Caroline Brorsson, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 982-988
Open Access | Times Cited: 88
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023)
Jürgen Harreiter, Michael Roden
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. S1, pp. 7-17
Open Access | Times Cited: 87
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top